Longevity Health Holdings, Inc. (XAGE)

Market Cap	732.70K -90.1%
Revenue (ttm)	1.91M +3,701.4%
Net Income	-6.91M
EPS	-4.83
Shares Out	2.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170
Average Volume	4,234
Open	0.2960
Previous Close	0.2810
Day's Range	0.2960 - 0.2960
52-Week Range	0.2530 - 9.3090
Beta	0.28
RSI	46.83
Earnings Date	Apr 9, 2026

About Longevity Health Holdings

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The company also develops a microemulsion formula...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2008
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: XAGE

Financial Performance

In 2025, Longevity Health Holdings's revenue was $1.91 million, an increase of 3701.44% compared to the previous year's $50,318. Losses were -$6.91 million, -33.40% less than in 2024.